Valuation Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 16:00:02 2026-01-23 EST			5-day change	1st Jan Change
108.18 ^USD	-0.92%		-0.60%	+2.77%

01-22	SK Bioscience, MSD, and Hilleman Laboratories Advance Zaire Ebolavirus Vaccine Development with CEPI Funding	CI
01-22	JPMorgan Adjusts Price Target on Merck & Co. to $125 From $120, Maintains Overweight Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	206,957	193,588	281,302	276,259	251,648	268,505	268,505	-
Change	-	-6.46%	45.31%	-1.79%	-8.91%	6.7%	0%	-
Enterprise Value (EV) ¹	230,686	218,594	298,801	304,221	275,517	293,085	286,393	269,881
Change	-	-5.24%	36.69%	1.81%	-9.44%	6.38%	-2.28%	-5.77%
P/E ratio	29.4x	14.9x	19.4x	779x	14.8x	13.9x	19.1x	11.7x
PBR	8.18x	5.07x	6.12x	7.34x	5.44x	4.99x	4.39x	3.54x
PEG	-	0.2x	1.7x	-8x	0x	0.9x	-0.7x	0.2x
Capitalization / Revenue	4.31x	3.97x	4.75x	4.6x	3.92x	4.14x	3.97x	3.77x
EV / Revenue	4.81x	4.49x	5.04x	5.06x	4.29x	4.52x	4.23x	3.79x
EV / EBITDA	11.2x	10.5x	11.3x	30.2x	9.88x	9.78x	12x	8.03x
EV / EBIT	13.6x	12.4x	13.3x	49x	11.8x	11x	14.1x	8.93x
EV / FCF	41.4x	25.2x	20.3x	33.3x	15.2x	12.6x	16.6x	10.5x
FCF Yield	2.41%	3.97%	4.92%	3.01%	6.57%	7.91%	6.02%	9.5%
Dividend per Share ²	2.48	2.64	2.8	2.96	3.12	3.229	3.252	3.535
Rate of return	3.03%	3.44%	2.52%	2.72%	3.14%	2.99%	3.01%	3.27%
EPS ²	2.78	5.14	5.71	0.14	6.74	7.808	5.674	9.217
Distribution rate	89.2%	51.4%	49%	2,114%	46.3%	41.4%	57.3%	38.3%
Net sales ¹	47,994	48,704	59,283	60,115	64,168	64,791	67,677	71,188
EBITDA ¹	20,570	20,910	26,431	10,083	27,897	29,969	23,875	33,606
EBIT ¹	16,945	17,696	22,522	6,211	23,398	26,731	20,288	30,219
Net income ¹	7,067	13,049	14,519	365	17,117	20,084	14,475	22,613
Net Debt ¹	23,729	25,006	17,499	27,962	23,869	24,580	17,888	1,376
Reference price ²	81.80	76.64	110.95	109.02	99.48	108.18	108.18	108.18
Nbr of stocks (in thousands)	2,530,034	2,525,944	2,535,396	2,534,023	2,529,636	2,482,023	2,482,023	-
Announcement Date	2/4/21	2/3/22	2/2/23	2/1/24	2/4/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MERCK & CO., INC.	13.85x	4.52x	9.78x	2.99%	269B
ELI LILLY AND COMPANY	46.69x	15.38x	34.34x	0.55%	953B
JOHNSON & JOHNSON	21.28x	5.92x	16.45x	2.34%	530B
ABBVIE INC.	63.81x	7.28x	17.46x	2.98%	388B
ROCHE HOLDING AG	20.44x	5.07x	12.62x	2.84%	377B
ASTRAZENECA PLC	28.26x	5.26x	15.58x	1.76%	286B
NOVARTIS AG	20.66x	5.43x	12.76x	2.83%	281B
NOVO NORDISK A/S	17.41x	6.13x	12.61x	2.9%	281B
AMGEN INC.	26.94x	6.34x	10.84x	2.77%	186B
GILEAD SCIENCES, INC.	20.28x	6.21x	11.37x	2.44%	169B
Average	27.96x	6.75x	15.38x	2.44%	371.91B
Weighted average by Cap.	32.04x	8.26x	19.12x	2.11%